You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)

Docket ⤷  Sign Up Date Filed 2016-11-30
Court District Court, D. Delaware Date Terminated 2020-01-21
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Defendant Referred To
Parties ALLERGAN USA, INC.
Patents 6,660,715; 6,858,650; 7,041,786; 7,304,036; 7,371,727; 7,384,980; 7,476,652; 7,704,947; 7,713,930; 7,745,409; 7,771,707; 7,855,230; 7,985,772; 8,080,526; 8,110,553; 8,338,478; 8,449,909; 8,557,291; 8,618,049; 8,679,069; 8,748,573; 8,758,813; 8,802,628; 8,822,438; 8,933,030; 8,992,486; 9,044,398; 9,248,195; 9,285,372; 9,339,507; 9,358,240; 9,526,844; 9,592,200; 9,604,008; 9,708,371; 9,763,883; RE38,551; RE44,186
Attorneys Nathan R. Gilbert
Firms Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc.

The biologic drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2018-05-09 169 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,708,371 B2 . (Vrana, Robert…2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware External link to document
2018-06-12 183 Stipulation to EXTEND Time Discovery, including ESI, with repsect to U.S. Patent No. 9,708,371 and MPI's ANDA to June 27, 2018 - filed …2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware External link to document
2018-06-26 191 Stipulation to EXTEND Time Standard for Discovery with Respect to U.S. Patent No. 9,708,371 and MPI's ANDA to July 5, 2018 - filed by…2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.